Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OBSERVATIONAL STUDY OF TOFACITINIB IN ULCERATIVE COLITIS IN SWEDEN (ODEN)

NCT04338204 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04338204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04338204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OBSERVATIONAL STUDY OF TOFACITINIB IN ULCERATIVE COLITIS IN SWEDEN (ODEN)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
September 14, 2020
Completion date
September 30, 2025
Enrollment
102 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis